B-Cell Lymphoma with Novartis Kymriah, Adult
Kymriah, developed by Novartis, is a type of immunotherapy for young adults (up to 25 years of age) with B-Cell Lymphoma. Through Kymriah therapy, a patient's T-cells are genetically reprogrammed to fight cancer cells.
3 Result(s)
Distance
13 Miles
1171 Miles
2433 Miles
Details